Nora Volkow, M.D., Director of the National Institute on Drug Abuse, NIH
"Drug Addiction as a Disease of the Human Brain"
12:00 pm - 1:00 pm
Laureate Psychiatric Clinic and Hospital Conference Center
Nora Volkow M.D., is Director of the National Institute on Drug Abuse at the National Institutes of Health (NIH). Over the past 30 years, she has published more than 770 peer-reviewed articles, more than 95 book chapters, edited four books on brain imaging and addiction and co-edited an Encyclopedia on Neuroscience. She has received multiple awards including membership in the National Academy of Medicine in 2000 and the International Prize for Science from the French Institute of Health and Medical Research in 2009. She was named one of Time magazine’s “Top 100 People Who Shape Our World”, “One of 20 People to Watch”, by Newsweek magazine and “Innovator of the Year” by U.S. News & World Report. Her work as a researcher and as a leader has been instrumental in transforming the paradigm of drug addiction from that of a behavioral choice to that of a treatable brain disease.
"Drug Addiction as a Disease of the Human Brain"
12:00 pm - 1:00 pm
Laureate Psychiatric Clinic and Hospital Conference Center
Nora Volkow M.D., is Director of the National Institute on Drug Abuse at the National Institutes of Health (NIH). Over the past 30 years, she has published more than 770 peer-reviewed articles, more than 95 book chapters, edited four books on brain imaging and addiction and co-edited an Encyclopedia on Neuroscience. She has received multiple awards including membership in the National Academy of Medicine in 2000 and the International Prize for Science from the French Institute of Health and Medical Research in 2009. She was named one of Time magazine’s “Top 100 People Who Shape Our World”, “One of 20 People to Watch”, by Newsweek magazine and “Innovator of the Year” by U.S. News & World Report. Her work as a researcher and as a leader has been instrumental in transforming the paradigm of drug addiction from that of a behavioral choice to that of a treatable brain disease.